Cargando…
Therapeutic Efficiency of Nasal Mucosa-Derived Ectodermal Mesenchymal Stem Cells in Rats with Acute Hepatic Failure
BACKGROUND: Liver transplantation is limited by the insufficiency of liver organ donors when treating end-stage liver disease or acute liver failure (ALF). Ectodermal mesenchymal stem cells (EMSCs) derived from nasal mucosa have emerged as an alternative cell-based therapy. However, the role of EMSC...
Autores principales: | Xiang, Wen, Wang, Xinhe, Yu, Xinghui, Xie, Yan, Zhang, Li, Lu, Naiyan, Jiang, Wentao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9842420/ https://www.ncbi.nlm.nih.gov/pubmed/36655034 http://dx.doi.org/10.1155/2023/6890299 |
Ejemplares similares
-
Nasal Mucosa Derived-Mesenchymal Stem Cells from Mice Reduce Inflammation via Modulating Immune Responses
por: Yang, Chen, et al.
Publicado: (2015) -
Stem cells in ectodermal development
por: Benitah, Salvador Aznar, et al.
Publicado: (2012) -
Comparison of Biological Properties and Clinical Application of Mesenchymal Stem Cells from the Mesoderm and Ectoderm
por: Wang, Zhenning, et al.
Publicado: (2023) -
Rapid and robust derivation of mesenchymal stem cells from human pluripotent stem cells via temporal induction of neuralized ectoderm
por: Jin, Wei, et al.
Publicado: (2022) -
Therapeutic Interaction of Systemically-Administered Mesenchymal Stem Cells with Peri-Implant Mucosa
por: Kondo, Ryosuke, et al.
Publicado: (2014)